nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA1—cardiovascular system—nicotine dependence	0.0538	0.182	CbGeAlD
Lithium—GSK3B—cardiovascular system—nicotine dependence	0.0396	0.134	CbGeAlD
Lithium—GRIA3—midbrain—nicotine dependence	0.0357	0.121	CbGeAlD
Lithium—GSK3A—cardiovascular system—nicotine dependence	0.0344	0.117	CbGeAlD
Lithium—Polydipsia—Varenicline—nicotine dependence	0.0328	0.0823	CcSEcCtD
Lithium—GSK3A—midbrain—nicotine dependence	0.0269	0.091	CbGeAlD
Lithium—IMPA1—brain—nicotine dependence	0.0264	0.0894	CbGeAlD
Lithium—GRIA3—brain—nicotine dependence	0.0225	0.076	CbGeAlD
Lithium—GRIA3—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.0202	0.0659	CbGpPWpGaD
Lithium—IMPA2—brain—nicotine dependence	0.0198	0.0671	CbGeAlD
Lithium—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0196	0.0492	CcSEcCtD
Lithium—GSK3B—brain—nicotine dependence	0.0194	0.0658	CbGeAlD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0191	0.0625	CbGpPWpGaD
Lithium—Sexual dysfunction—Varenicline—nicotine dependence	0.0182	0.0455	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.0181	0.0592	CbGpPWpGaD
Lithium—GSK3A—brain—nicotine dependence	0.0169	0.0572	CbGeAlD
Lithium—Psoriasis—Varenicline—nicotine dependence	0.0162	0.0406	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0143	0.047	CbGpPWpGaD
Lithium—Nystagmus—Varenicline—nicotine dependence	0.0142	0.0357	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0136	0.0445	CbGpPWpGaD
Lithium—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0135	0.0339	CcSEcCtD
Lithium—Scotoma—Varenicline—nicotine dependence	0.0134	0.0336	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.0131	0.0428	CbGpPWpGaD
Lithium—Glycosuria—Varenicline—nicotine dependence	0.0126	0.0315	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0125	0.041	CbGpPWpGaD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.0117	0.0382	CbGpPWpGaD
Lithium—Chest discomfort—Varenicline—nicotine dependence	0.0115	0.0288	CcSEcCtD
Lithium—GRIA3—Neuronal System—CHRNB3—nicotine dependence	0.011	0.036	CbGpPWpGaD
Lithium—Leukocytosis—Varenicline—nicotine dependence	0.0108	0.0271	CcSEcCtD
Lithium—Dysarthria—Varenicline—nicotine dependence	0.0108	0.027	CcSEcCtD
Lithium—GRIA3—Neuronal System—CHRNA6—nicotine dependence	0.0104	0.0341	CbGpPWpGaD
Lithium—Coordination abnormal—Varenicline—nicotine dependence	0.0104	0.026	CcSEcCtD
Lithium—Salivary hypersecretion—Varenicline—nicotine dependence	0.00988	0.0248	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00983	0.0322	CbGpPWpGaD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00951	0.0311	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00943	0.0309	CbGpPWpGaD
Lithium—Urine output increased—Varenicline—nicotine dependence	0.0092	0.0231	CcSEcCtD
Lithium—Hypertonia—Varenicline—nicotine dependence	0.00892	0.0224	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00877	0.0287	CbGpPWpGaD
Lithium—Polyuria—Varenicline—nicotine dependence	0.00841	0.0211	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00837	0.0274	CbGpPWpGaD
Lithium—Thirst—Varenicline—nicotine dependence	0.00776	0.0195	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.0076	0.0249	CbGpPWpGaD
Lithium—Lethargy—Varenicline—nicotine dependence	0.00754	0.0189	CcSEcCtD
Lithium—GRIA3—Neuronal System—GABRA4—nicotine dependence	0.00754	0.0247	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—CHRNB4—nicotine dependence	0.00722	0.0236	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00715	0.0234	CbGpPWpGaD
Lithium—Dry skin—Varenicline—nicotine dependence	0.00677	0.017	CcSEcCtD
Lithium—GRIA3—Neuronal System—CHRNA5—nicotine dependence	0.00672	0.022	CbGpPWpGaD
Lithium—Gastritis—Varenicline—nicotine dependence	0.00654	0.0164	CcSEcCtD
Lithium—GSK3A—Signaling by NGF—FGD1—nicotine dependence	0.00645	0.0211	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00629	0.0206	CbGpPWpGaD
Lithium—Erectile dysfunction—Varenicline—nicotine dependence	0.00588	0.0147	CcSEcCtD
Lithium—Weight increased—Varenicline—nicotine dependence	0.00581	0.0146	CcSEcCtD
Lithium—Hyperglycaemia—Varenicline—nicotine dependence	0.00576	0.0144	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00571	0.0187	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—CHRNA3—nicotine dependence	0.00548	0.0179	CbGpPWpGaD
Lithium—Bradycardia—Varenicline—nicotine dependence	0.0052	0.013	CcSEcCtD
Lithium—Hallucination—Varenicline—nicotine dependence	0.00508	0.0127	CcSEcCtD
Lithium—GRIA3—Neuronal System—CHRNB2—nicotine dependence	0.00482	0.0158	CbGpPWpGaD
Lithium—Tinnitus—Varenicline—nicotine dependence	0.00476	0.0119	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—FGD1—nicotine dependence	0.00476	0.0156	CbGpPWpGaD
Lithium—Arrhythmia—Varenicline—nicotine dependence	0.00456	0.0114	CcSEcCtD
Lithium—Flatulence—Varenicline—nicotine dependence	0.00438	0.011	CcSEcCtD
Lithium—GRIA3—Neuronal System—CHRNA4—nicotine dependence	0.00438	0.0143	CbGpPWpGaD
Lithium—Dysgeusia—Varenicline—nicotine dependence	0.00436	0.0109	CcSEcCtD
Lithium—Vision blurred—Varenicline—nicotine dependence	0.00419	0.0105	CcSEcCtD
Lithium—Tremor—Varenicline—nicotine dependence	0.00417	0.0104	CcSEcCtD
Lithium—Agitation—Varenicline—nicotine dependence	0.00409	0.0102	CcSEcCtD
Lithium—Angioedema—Varenicline—nicotine dependence	0.00406	0.0102	CcSEcCtD
Lithium—IMPA2—Metabolism—CYP2A7—nicotine dependence	0.00405	0.0133	CbGpPWpGaD
Lithium—Vertigo—Varenicline—nicotine dependence	0.004	0.01	CcSEcCtD
Lithium—Syncope—Varenicline—nicotine dependence	0.00399	0.01	CcSEcCtD
Lithium—Loss of consciousness—Varenicline—nicotine dependence	0.00391	0.0098	CcSEcCtD
Lithium—Convulsion—Varenicline—nicotine dependence	0.00385	0.00966	CcSEcCtD
Lithium—Arthralgia—Varenicline—nicotine dependence	0.00379	0.00949	CcSEcCtD
Lithium—Discomfort—Varenicline—nicotine dependence	0.00374	0.00938	CcSEcCtD
Lithium—Dry mouth—Varenicline—nicotine dependence	0.0037	0.00928	CcSEcCtD
Lithium—Oedema—Varenicline—nicotine dependence	0.00363	0.0091	CcSEcCtD
Lithium—IMPA1—Metabolism—CYP2A7—nicotine dependence	0.00361	0.0118	CbGpPWpGaD
Lithium—Shock—Varenicline—nicotine dependence	0.00357	0.00895	CcSEcCtD
Lithium—Anorexia—Varenicline—nicotine dependence	0.00346	0.00867	CcSEcCtD
Lithium—Hypotension—Varenicline—nicotine dependence	0.00339	0.0085	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00332	0.0109	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00331	0.00829	CcSEcCtD
Lithium—Somnolence—Varenicline—nicotine dependence	0.00323	0.00809	CcSEcCtD
Lithium—Dyspepsia—Varenicline—nicotine dependence	0.0032	0.00801	CcSEcCtD
Lithium—Decreased appetite—Varenicline—nicotine dependence	0.00316	0.00791	CcSEcCtD
Lithium—Fatigue—Varenicline—nicotine dependence	0.00313	0.00785	CcSEcCtD
Lithium—Feeling abnormal—Varenicline—nicotine dependence	0.00299	0.0075	CcSEcCtD
Lithium—Gastrointestinal pain—Varenicline—nicotine dependence	0.00297	0.00744	CcSEcCtD
Lithium—Body temperature increased—Varenicline—nicotine dependence	0.00287	0.00719	CcSEcCtD
Lithium—Abdominal pain—Varenicline—nicotine dependence	0.00287	0.00719	CcSEcCtD
Lithium—Asthenia—Varenicline—nicotine dependence	0.0026	0.00653	CcSEcCtD
Lithium—Diarrhoea—Varenicline—nicotine dependence	0.00248	0.00623	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—DRD2—nicotine dependence	0.00245	0.00803	CbGpPWpGaD
Lithium—Dizziness—Varenicline—nicotine dependence	0.0024	0.00602	CcSEcCtD
Lithium—Vomiting—Varenicline—nicotine dependence	0.00231	0.00579	CcSEcCtD
Lithium—Rash—Varenicline—nicotine dependence	0.00229	0.00574	CcSEcCtD
Lithium—GSK3A—Innate Immune System—WASF2—nicotine dependence	0.00229	0.00749	CbGpPWpGaD
Lithium—Dermatitis—Varenicline—nicotine dependence	0.00229	0.00573	CcSEcCtD
Lithium—Headache—Varenicline—nicotine dependence	0.00227	0.0057	CcSEcCtD
Lithium—GSK3A—Innate Immune System—WASF1—nicotine dependence	0.00219	0.00718	CbGpPWpGaD
Lithium—Nausea—Varenicline—nicotine dependence	0.00216	0.00541	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—TAS2R16—nicotine dependence	0.00176	0.00577	CbGpPWpGaD
Lithium—GSK3A—Disease—AKR1B10—nicotine dependence	0.00175	0.00572	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—WASF2—nicotine dependence	0.00169	0.00553	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—WASF1—nicotine dependence	0.00162	0.00531	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGD1—nicotine dependence	0.00138	0.00453	CbGpPWpGaD
Lithium—GSK3A—Immune System—WASF2—nicotine dependence	0.00133	0.00436	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TAS2R16—nicotine dependence	0.0013	0.00427	CbGpPWpGaD
Lithium—GSK3B—Disease—AKR1B10—nicotine dependence	0.00129	0.00422	CbGpPWpGaD
Lithium—GSK3A—Immune System—WASF1—nicotine dependence	0.00128	0.00418	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKR1B10—nicotine dependence	0.00122	0.004	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGD1—nicotine dependence	0.00102	0.00335	CbGpPWpGaD
Lithium—GSK3B—Immune System—WASF2—nicotine dependence	0.000985	0.00322	CbGpPWpGaD
Lithium—GSK3B—Immune System—WASF1—nicotine dependence	0.000944	0.00309	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKR1B10—nicotine dependence	0.000904	0.00296	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WASF2—nicotine dependence	0.000862	0.00282	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—WASF1—nicotine dependence	0.000826	0.0027	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—OPRM1—nicotine dependence	0.000744	0.00243	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WASF2—nicotine dependence	0.000637	0.00208	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WASF1—nicotine dependence	0.000611	0.002	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—OPRM1—nicotine dependence	0.00055	0.0018	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD2—nicotine dependence	0.000538	0.00176	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD2—nicotine dependence	0.000397	0.0013	CbGpPWpGaD
